Coromandel International Limited has informed the Exchange regarding 'updates'.
COROMANDEL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coromandel International has resubmitted its audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, in a more legible format at the request of NSE, after the original machine-readable filing was deemed difficult to read due to low scanning DPI. For FY25 on a standalone basis, total income stood at around Rs. 24,085 crore with net profit attributable to owners of about Rs. 2,055 crore and basic EPS of roughly Rs. 69.67. On a consolidated basis, FY25 total income was about Rs. 24,268 crore with net profit attributable to owners of around Rs. 1,937 crore and basic EPS near Rs. 65.96. Q4 FY25 standalone net profit was about Rs. 389 crore, while consolidated Q4 net profit was approximately Rs. 578 crore. The audit was carried out by S.R. Batliboi & Associates LLP, who issued an unqualified opinion. Two new Senegal-based entities, Baobab Mining and Chemicals Corporation S.A. and Gadde Bissik Phosphates Operations Suarl, were added as subsidiaries with effect from March 27, 2025, while the joint venture with Yanmar Coromandel Agrisolutions ended on September 27, 2024.
This is largely a procedural resubmission for legibility and does not represent new financial information, so no immediate stock price reaction is expected. The underlying FY25 results, however, show healthy profitability and the addition of Senegal phosphate assets expands Coromandel's international footprint, which may support long-term growth in the nutrient business.